Overview
Humanized immune-checkpoint mouse models are genetically engineered to replace key inhibitory immune receptors, such as PD-1, PD-L1, and CTLA-4, with their human equivalents. These models faithfully replicate human immune-regulatory pathways and are essential for evaluating antibody and biologic therapies.
Frequently Asked Questions
Why humanize immune checkpoints?
Mouse and human checkpoint proteins differ structurally, preventing direct translation of therapeutic results. Humanization enables human antibody binding and accurate mechanistic studies.